Suggestions
Martin Felsenthal
Partner at Health Velocity Capital
Professional Background
Marty Felsenthal is a distinguished venture capital and growth stage investor with an impressive career spanning over three decades, during which he has dedicated himself to the innovative realm of healthcare services and healthcare software companies. Since 1992, he has been at the forefront of financing and nurturing businesses that have spearheaded the creation of new sectors within the healthcare landscape, establishing themselves as market leaders. His extensive experience and strategic vision have made him a sought-after partner among entrepreneurs and executives in the healthcare space.
Throughout his career, Marty has spearheaded investments in many industry-shaping companies while also serving on their Boards of Directors. Notable examples of his contributions include companies like Teladoc (NYSE: TDOC), Change Healthcare, and US Renal Care, among others. His role has often gone beyond investment—he has actively participated in shaping the direction of these companies, helping them achieve significant growth milestones and building valuable customer relationships. Marty's commitment to empowering healthcare innovation is evident, as he has led over 70% of his firm's financings while successfully fostering connections across the industry. Through his work, he has not only driven significant investments but also played a crucial role in the overall management of diverse funds, collaborating with some of the nation’s largest healthcare payers, health systems, and foundations.
Education and Achievements
Marty's educational background set a robust foundation for his success in the competitive fields of venture capital and healthcare investment. He holds a Bachelor of Arts degree from the prestigious Princeton University, where he honed his analytical and strategic thinking skills. Following his undergraduate studies, he pursued a Master of Business Administration at Stanford University Graduate School of Business, one of the world’s leading institutions for business education. This combination of rigorous academic training and practical experience has positioned him as a thought leader and pivotal figure in the investment community.
With a storied history of leadership roles at various organizations, Marty has consistently contributed to the growth of healthcare innovation. Among his key roles, he is a member of the Board of Directors at Clever Care Health Plan, where his insights continue to shape the company's trajectory. Previously, he served on the Boards of InSight Telepsychiatry, Well Health Inc., IVX Health, and MDLIVE, showcasing his versatility and commitment to advancing healthcare technology and services.
Moreover, Marty's experience as a partner at prominent venture capital firms such as Health Velocity Capital and HLM Venture Partners highlights his strategic prowess in fund management and investment decision-making. He has enjoyed working with talented executives and teams, successfully recruiting over 75 leaders for his portfolio companies and playing an instrumental role in expanding their customer bases and market reach. His collaborations extend across influential healthcare organizations, enabling him to build significant relationships that have enhanced the success of various ventures.
Notable Investments and Contributions
Marty's investment portfolio is a testament to his foresight and deep understanding of the healthcare sector. He has been instrumental in guiding the growth of high-impact companies that have achieved notable success through acquisition and expansion. For instance, firms like Change Healthcare and Aperio have benefitted significantly from his strategic insights and investment decisions.
His acute ability to identify promising startups and scale them into successful enterprises has made a lasting impact on the landscape of healthcare innovation. Companies such as Titan Health, which was acquired by United Surgical Partners, and Vantage Oncology, acquired by McKesson, underscore the remarkable outcomes that have been realized under his guidance. Furthermore, his participation in the investment of US Renal Care, which was acquired by Leonard Green, illustrates his dedication to driving substantial advancements in healthcare delivery.
In addition to his investment activities, Marty’s experience with strategic board roles has allowed him to influence the governance structures and growth strategies of numerous healthcare ventures. His input as a Board Observer at RedBrick Health and his advisory roles at the California Health Care Foundation’s Innovation Fund highlight his commitment to fostering innovation and addressing pressing healthcare challenges.
Achievements
Marty Felsenthal's trajectory in the venture capital landscape has been marked with significant achievements that exemplify his industry expertise and unwavering dedication to healthcare advancements. His leadership alongside seasoned executives has contributed to the elevation of several companies, ensuring they achieve their vision while navigating the complexities of healthcare investment.
He has successfully steered funds that empowered emerging healthcare technology companies, proving to be a strategic ally for founders and CEOs alike. Marty is recognized for his ability to forge meaningful connections, enhance operations through collaborative efforts, and create lasting partnerships that benefit all stakeholders in the healthcare ecosystem.
His impressive track record reflects not only his financial acumen but also his genuine passion for improving healthcare delivery through innovative, effective solutions. Marty Felsenthal is undoubtedly a respected figure in venture capital, who continues to influence the next wave of healthcare innovation.
